Search

everythinglearnresearchcommunity

for

Search:↓

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Mice with human gene experienced hair loss when treated with DHT.

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

Higher androgen levels and site-specific AR expression cause sex-related skeletal differences, and certain steroids can boost AR expression and androgen effects in bone cells.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

The gel made of minoxidil and hydroxypropyl-β-cyclodextrin improves hair growth and is good for long-term use.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

No clear link between androgen receptor variation and hair loss, but more research needed.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Women with hair loss have more androgen receptors in certain hair follicles.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

Personalized treatments for hair loss are becoming more effective by using genetic information.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Mutations in certain receptors can cause diseases and offer new treatment options.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.